Is an integrated approach warranted for concomitant carotid and coronary artery disease?

T J Takach1, G J Reul, D A Cooley

  • 1Department of Cardiovascular Surgery, Texas Heart Institute, Houston 77225-0345, USA.

Insights

Simultaneous treatment of coronary and carotid artery disease shows similar outcomes to staged approaches, especially since 1986. Advances in cardiac care have improved safety for both methods in managing these complex vascular conditions.

Area of Science:

  • Cardiovascular Surgery
  • Vascular Surgery
  • Interventional Cardiology

Background:

  • Management of severe, combined coronary and carotid artery occlusive disease presents a clinical challenge.
  • Controversy exists regarding the optimal surgical strategy for these patients.

Purpose of the Study:

  • To compare outcomes of simultaneous versus staged surgical treatment for patients with concomitant coronary and carotid artery occlusive disease.
  • To identify predictors of adverse outcomes in this patient population.

Main Methods:

  • A retrospective analysis of 512 patients undergoing coronary revascularization between 1975 and 1996.
  • Patients were divided into two groups: simultaneous coronary revascularization and carotid endarterectomy (Group 1) or staged approach (Group 2).
  • Outcomes including stroke, death, and myocardial infarction were compared between groups, with analysis stratified by year (before and after 1986).

Main Results:

  • Before 1986, Group 1 had significantly higher rates of stroke and death compared to Group 2.
  • Since 1986, outcomes for stroke, death, and myocardial infarction were similar between the simultaneous (Group 1) and staged (Group 2) treatment approaches.
  • Heart-related factors such as reoperation, intra-aortic balloon use, low ejection fraction, and severe angina were predictors of death; older age and heart failure predicted stroke.

Conclusions:

  • Contemporary surgical results suggest that a staged treatment approach offers no advantage over simultaneous treatment for severe, concomitant coronary and carotid artery occlusive disease.
  • Improvements in myocardial protection and perioperative hemodynamic management likely contribute to the reduced incidences of stroke and death observed in recent years.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...